VistaGen finds open-label success with social anxiety nasal spray, but PALISADE pivotal trial remains iced

VistaGen’s beleaguered social anxiety spray may be back on hold, but that hasn’t stopped the biotech from touting separate open-label data that the company says show the therapy is safe and will work on an as-needed basis.